TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
PLX

Protalix Biotherapeutics Inc

Healthcare · Biotechnology

2.80$ -1.4% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Protalix Biotherapeutics Inc (PLX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 110 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PLX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
88 84 90 92 62 73 74 78 82 82 102 110
73 70 75 77 48 60 61 65 67 67 86 92
20 24 27 23 27 20 19 18 14 15 42 27
41 45 48 45 27 35 35 33 29 30 52 41
8.9 5.3 3.8 10 2.2 2.9 4.7 9.4 14 8.8 2.9 17
22 19 22 21 17 21 20 21 21 26 30 32
11 10 10 10.0 9.7 13 13
49 51 60 63 29 30 29 29 29 34 35 39
43 46 55 58 24 26 24 24 22 27 27 31
22 22 22 23 1.5 1.5 1.4 1.5 1.4 1.4 1.4 1.7
3.1 4.3 3.1 4.1 3.1 4.5 4.1 6.7 5.4 5.3 4.3 6.5
38 34 30 29 32 43 45 50 53 48 67 71
-376 -382 -386 -388 -385 -378 -382 -382 -379 -385 -367 -363
84 73 73 73 81 81 77 81 81 79 83 83

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?